ArticleCancer medicine2022

Regorafenib for Taiwanese patients with unresectable hepatocellular carcinoma after sorafenib failure: Impact of alpha-fetoprotein levels.

Po-Yao Hsu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.